These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 32385164

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Interim FDG18-PET SUVmax Variation Adds Prognostic Value to Deauville 5-Point Scale in the Identification of Patients with Ultra-High-Risk Diffuse Large B Cell Lymphoma.
    Duarte S, Roque A, Saraiva T, Afonso C, Marques BA, Lima CB, Neves D, Lai AC, Costa G, Cipriano A, Geraldes C, Ruzickova L, Carda JP, Gomes M.
    Clin Lymphoma Myeloma Leuk; 2023 Feb; 23(2):e107-e116. PubMed ID: 36567213
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Optimisation of metabolic criteria in the prognostic assessment in patients with lymphoma. A multicentre study.
    Del Puig Cózar-Santiago M, García-Garzón JR, Moragas-Freixa M, Soler-Peter M, Bassa Massanas P, Sánchez-Delgado M, Sanchez-Jurado R, Aguilar-Barrios JE, Sanz-Llorens R, Ferrer-Rebolleda J.
    Rev Esp Med Nucl Imagen Mol; 2017 Feb; 36(5):304-311. PubMed ID: 28483373
    [Abstract] [Full Text] [Related]

  • 6. Interim PET in Diffuse Large B-Cell Lymphoma.
    Kurch L, Hüttmann A, Georgi TW, Rekowski J, Sabri O, Schmitz C, Kluge R, Dührsen U, Hasenclever D.
    J Nucl Med; 2021 Aug 01; 62(8):1068-1074. PubMed ID: 33246974
    [Abstract] [Full Text] [Related]

  • 7. Improved prediction of chemoresistance in patients with diffuse large B-cell lymphoma through a new interim positron emission tomography-computed tomography evaluation model.
    Xie W, Liu MK, Jiang XF, Gao XD, Li B, Wang L, Zhao WL.
    Acta Oncol; 2021 Jun 01; 60(6):735-743. PubMed ID: 33720799
    [Abstract] [Full Text] [Related]

  • 8. Validation of the ΔSUVmax for Interim PET Interpretation in Diffuse Large B-Cell Lymphoma on the Basis of the GAINED Clinical Trial.
    Itti E, Blanc-Durand P, Berriolo-Riedinger A, Kanoun S, Kraeber-Bodéré F, Meignan M, Gat E, Gouill SL, Casasnovas RO, Bodet-Milin C.
    J Nucl Med; 2023 Nov 01; 64(11):1706-1711. PubMed ID: 37734837
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Combined Visual and Semiquantitative Evaluation Improves Outcome Prediction by Early Midtreatment 18F-FDG PET in Diffuse Large B-Cell Lymphoma.
    Györke T, Carr R, Cerci JJ, Meneghetti C, Redondo F, Celli M, Gorospe C, Auewarakul CU, Jorgov L, Paez D, Fanti S.
    J Nucl Med; 2020 Jul 01; 61(7):999-1005. PubMed ID: 31757842
    [Abstract] [Full Text] [Related]

  • 13. An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and ΔSUVmax.
    Itti E, Meignan M, Berriolo-Riedinger A, Biggi A, Cashen AF, Véra P, Tilly H, Siegel BA, Gallamini A, Casasnovas RO, Haioun C.
    Eur J Nucl Med Mol Imaging; 2013 Sep 01; 40(9):1312-20. PubMed ID: 23649463
    [Abstract] [Full Text] [Related]

  • 14. Prediction of outcome in pediatric Hodgkin lymphoma based on interpretation of 18FDG-PET/CT according to ΔSUVmax, Deauville 5-point scale and IHP criteria.
    Isik EG, Kuyumcu S, Kebudi R, Sanli Y, Karakas Z, Cakir FB, Unal SN.
    Ann Nucl Med; 2017 Nov 01; 31(9):660-668. PubMed ID: 28741053
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prognostic parameters on baseline and interim [ 18 F]FDG-PET/computed tomography in diffuse large B-cell lymphoma patients.
    Czibor S, Carr R, Redondo F, Auewarakul CU, Cerci JJ, Paez D, Fanti S, Györke T.
    Nucl Med Commun; 2023 Apr 01; 44(4):291-301. PubMed ID: 36705233
    [Abstract] [Full Text] [Related]

  • 20. Prognostic models integrating quantitative parameters from baseline and interim positron emission computed tomography in patients with diffuse large B-cell lymphoma: post-hoc analysis from the SAKK38/07 clinical trial.
    Zucca E, Cascione L, Ruberto T, Facchinelli D, Schär S, Hayoz S, Dirnhofer S, Giovanella L, Bargetzi M, Mamot C, Ceriani L.
    Hematol Oncol; 2020 Dec 01; 38(5):715-725. PubMed ID: 32947651
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.